Biochips Market

Biochips Market contains market size and forecasts of Biochips (Microarrays/Microfluidics) in global, including the following market information:

• Global Biochips (Microarrays/Microfluidics) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Biochips (Microarrays/Microfluidics) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Biochips (Microarrays/Microfluidics) companies in 2021 (%)

The global Biochips (Microarrays/Microfluidics) market was valued at 16960 million in 2021 and is projected to reach US$ 39240 million by 2028, at a CAGR of 12.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

DNA Chip Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biochips (Microarrays/Microfluidics) include Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid and Thermo Fisher and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Biochips (Microarrays/Microfluidics) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biochips (Microarrays/Microfluidics) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biochips (Microarrays/Microfluidics) Market Segment Percentages, by Type, 2021 (%)

• DNA Chip
• Lab-on-a-chip
• Protein Chip

Global Biochips (Microarrays/Microfluidics) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biochips (Microarrays/Microfluidics) Market Segment Percentages, by Application, 2021 (%)

• Academics Institutes
• Diagnostics Centers

Global Biochips (Microarrays/Microfluidics) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biochips (Microarrays/Microfluidics) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Biochips (Microarrays/Microfluidics) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Biochips (Microarrays/Microfluidics) revenues share in global market, 2021 (%)
• Key companies Biochips (Microarrays/Microfluidics) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Biochips (Microarrays/Microfluidics) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Agilent
• PerkinElmer
• Fluidigm
• Illumina
• GE Healthcare
• Bio-Rad Laboratories
• Cepheid
• Thermo Fisher
• Roche